PATENT CLAIM ANALYSIS

Application Number: 16289451
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "005400"]

Abstract:
The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Claim (Index 4):
The method of  claim 1 , wherein X\u2032 is a peptide sequence having formula Ib\u2032 (Ib\u2032) (SEQ\u2003ID\u2003NO:\u200314) X1-Thr-His-X4-X5-X6-X7-X8-Phe-X10 wherein X1 is Asp, Ida, pGlu, bhAsp or absent; X4 is Phe or Dpa; X5 is Pro or bhPro; X6 is Ile, Cys or Arg; X7 is Cys, Ile, Leu or Val; X8 is Ile, Lys, Glu, Phe, Gln or Arg; and X10 is Lys or absent; or having formula Ic\u2032 (Ic\u2032) (SEQ\u2003ID\u2003NO:\u200315) X1-Thr-His-X4-X5-Cys-I1e-X8-Phe-X10 wherein X1 is Asp, Ida, pGlu, bhAsp or absent; X4 is Phe or Dpa; X5 is Pro or bhPro; X8 is Ile, Lys, Glu, Phe, Gln or Arg; and X10 is Lys or absent.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775469', '15828214', '16037982', '14800627', '15442229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8829251187103155
- 35 USC 102 Novelty (BERT): 0.6930547008997222
- Combined Prediction Score: 0.8639380769292563
- Mean Citation Score: 708.0968359999997
- Max Citation Score: 889.48676
- Similarity Product: 739.0364412317991

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test